HCP
Overvalued by 197.4% based on the discounted cash flow analysis.
Market cap | $6.88 Billion |
---|---|
Enterprise Value | $6.29 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.98 |
Beta | 1.25 |
Outstanding Shares | 201,872,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -46.07 |
---|---|
PEG | 68.7 |
Price to Sales | 11.59 |
Price to Book Ratio | 5.8 |
Enterprise Value to Revenue | 9.61 |
Enterprise Value to EBIT | -35.22 |
Enterprise Value to Net Income | -52 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.26 |
No data
No data